In order to meet rising demand for its GMP nasal spray testing services, Melbourn Scientific has dedicated a laboratory to analysis of droplet size, particle characterization, spray pattern, plume geometry, and device performance testing. The company has also appointed Liz Parkhouse as business development executive for the nasal spray testing service.
According to the Melbourn, the facility is the first in Europe to offer comprehensive nasal spray testing. The laboratory’s equipment includes the Malvern Spraytec and Morphologi G3 and the Proveris SprayVIEW.
Melbourn Scientific CEO Mark Hammond commented, “We predicted a few years ago that nasal delivery of compounds would increase as companies realized the benefits of this route. A nasal device offers a user friendly, painless, non-invasive route for drug administration. We are now seeing evidence of continued growth and that clients recognize the advantages of working with partners that have expertise in this area of drug delivery and understand the formulation and analytical challenges that it brings.”
Hammond added, “Depending upon the drug and device properties there are a number of considerations for the formulation, here at Melbourn Scientific we have developed a range of screening tools to enable us to fast track formulation development of the product from simple solutions, through suspensions to dry powder blends using a wide range of excipients. Our formulation development is supported by standalone testing services with significant investment in specialist equipment. The new lab will make this available as a comprehensive service. “
Read the Melbourn Scientific press release.
